P28223 5HT2A_HUMAN
Gene name: HTR2A
Protein name: 5-hydroxytryptamine receptor 2A
List of molecules and drugs that target protein P28223
| # | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
|---|---|---|---|---|---|---|---|
| 1 | P28223_DB00246 | DB00246 | Ziprasidone | antagonist | Ki(nM) = 0.08 IC50(nM) = 0.42 | MVWVFYHBGMAFLY-UHFFFAOYSA-N | ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1 |
| 2 | P28223_DB00247 | DB00247 | Methysergide | antagonist | KPJZHOPZRAFDTN-NQUBZZJWSA-N | [H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO | |
| 3 | P28223_DB00248 | DB00248 | Cabergoline | agonist | KORNTPPJEAJQIU-KJXAQDMKSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC | |
| 4 | P28223_DB00315 | DB00315 | Zolmitriptan | agonist | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12 | |
| 5 | P28223_DB00320 | DB00320 | Dihydroergotamine | agonist | LUZRJRNZXALNLM-JGRZULCMSA-N | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O | |
| 6 | P28223_DB00321 | DB00321 | Amitriptyline | antagonist | KRMDCWKBEZIMAB-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 | |
| 7 | P28223_DB00334 | DB00334 | Olanzapine | antagonist | Ki(nM) = 0.42 IC50(nM) = 7.0 | KVWDHTXUZHCGIO-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 |
| 8 | P28223_DB00363 | DB00363 | Clozapine | antagonist | Ki(nM) = 1.4 IC50(nM) = 12.0 | QZUDBNBUXVUHMW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 |
| 9 | P28223_DB00370 | DB00370 | Mirtazapine | antagonist | Ki(nM) = 8.2 | RONZAEMNMFQXRA-UHFFFAOYSA-N | CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1 |
| 10 | P28223_DB00408 | DB00408 | Loxapine | antagonist | Ki(nM) = 2.0 | XJGVXQDUIWGIRW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2 |
| 11 | P28223_DB00409 | DB00409 | Remoxipride | other/unknown | Ki(nM) = 3100.0 | GUJRSXAPGDDABA-NSHDSACASA-N | CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC |
| 12 | P28223_DB00420 | DB00420 | Promazine | antagonist | ZGUGWUXLJSTTMA-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12 | |
| 13 | P28223_DB00434 | DB00434 | Cyproheptadine | antagonist | Ki(nM) = 0.46 | JJCFRYNCJDLXIK-UHFFFAOYSA-N | CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12 |
| 14 | P28223_DB00458 | DB00458 | Imipramine | antagonist | Ki(nM) = 94.0 | BCGWQEUPMDMJNV-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
| 15 | P28223_DB00477 | DB00477 | Chlorpromazine | antagonist | Ki(nM) = 1.8 | ZPEIMTDSQAKGNT-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2 |
| 16 | P28223_DB00502 | DB00502 | Haloperidol | other/unknown | Ki(nM) = 20.0 IC50(nM) = 288.0 | LNEPOXFFQSENCJ-UHFFFAOYSA-N | OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1 |
| 17 | P28223_DB00540 | DB00540 | Nortriptyline | antagonist | PHVGLTMQBUFIQQ-UHFFFAOYSA-N | CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 | |
| 18 | P28223_DB00543 | DB00543 | Amoxapine | antagonist | Ki(nM) = 1.77 | QWGDMFLQWFTERH-UHFFFAOYSA-N | ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1 |
| 19 | P28223_DB00555 | DB00555 | Lamotrigine | inhibitor | PYZRQGJRPPTADH-UHFFFAOYSA-N | NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1 | |
| 20 | P28223_DB00574 | DB00574 | Fenfluramine | agonist | Ki(nM) = 3801.89 | DBGIVFWFUFKIQN-UHFFFAOYSA-N | CCNC(C)CC1=CC=CC(=C1)C(F)(F)F |
| 21 | P28223_DB00589 | DB00589 | Lisuride | agonist | Ki(nM) = 6918.31 | BKRGVLQUQGGVSM-KBXCAEBGSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC |
| 22 | P28223_DB00604 | DB00604 | Cisapride | agonist | DCSUBABJRXZOMT-IRLDBZIGSA-N | CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC | |
| 23 | P28223_DB00623 | DB00623 | Fluphenazine | n/a | Ki(nM) = 3.2 | PLDUPXSUYLZYBN-UHFFFAOYSA-N | OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 |
| 24 | P28223_DB00656 | DB00656 | Trazodone | antagonist | Ki(nM) = 44.67 IC50(nM) = 243.0 | PHLBKPHSAVXXEF-UHFFFAOYSA-N | ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1 |
| 25 | P28223_DB00679 | DB00679 | Thioridazine | antagonist | Ki(nM) = 10.0 | KLBQZWRITKRQQV-UHFFFAOYSA-N | CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1 |
| 26 | P28223_DB00696 | DB00696 | Ergotamine | agonist | Ki(nM) = 0.64 | XCGSFFUVFURLIX-VFGNJEKYSA-N | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O |
| 27 | P28223_DB00714 | DB00714 | Apomorphine | agonist | Ki(nM) = 120.0 | VMWNQDUVQKEIOC-CYBMUJFWSA-N | [H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23 |
| 28 | P28223_DB00715 | DB00715 | Paroxetine | agonist | Ki(nM) = 10000.0 | AHOUBRCZNHFOSL-YOEHRIQHSA-N | FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1 |
| 29 | P28223_DB00726 | DB00726 | Trimipramine | agonist | ZSCDBOWYZJWBIY-UHFFFAOYSA-N | CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12 | |
| 30 | P28223_DB00734 | DB00734 | Risperidone | antagonist | Ki(nM) = 0.14 IC50(nM) = 0.707946 | RAPZEAPATHNIPO-UHFFFAOYSA-N | CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1 |
| 31 | P28223_DB00751 | DB00751 | Epinastine | antagonist | WHWZLSFABNNENI-UHFFFAOYSA-N | NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21 | |
| 32 | P28223_DB00777 | DB00777 | Propiomazine | antagonist | UVOIBTBFPOZKGP-UHFFFAOYSA-N | CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1 | |
| 33 | P28223_DB00805 | DB00805 | Minaprine | antagonist | LDMWSLGGVTVJPG-UHFFFAOYSA-N | CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1 | |
| 34 | P28223_DB00843 | DB00843 | Donepezil | inducer | ADEBPBSSDYVVLD-UHFFFAOYSA-N | COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1 | |
| 35 | P28223_DB00875 | DB00875 | Flupentixol | antagonist | NJMYODHXAKYRHW-DVZOWYKESA-N | [H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F | |
| 36 | P28223_DB00924 | DB00924 | Cyclobenzaprine | antagonist | JURKNVYFZMSNLP-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12 | |
| 37 | P28223_DB00933 | DB00933 | Mesoridazine | antagonist | SLVMESMUVMCQIY-UHFFFAOYSA-N | CN1CCCCC1CCN1C2=C(SC3=C1C=C(C=C3)S(C)=O)C=CC=C2 | |
| 38 | P28223_DB00934 | DB00934 | Maprotiline | binder | QSLMDECMDJKHMQ-UHFFFAOYSA-N | CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21 | |
| 39 | P28223_DB01079 | DB01079 | Tegaserod | antagonist | IKBKZGMPCYNSLU-RGVLZGJSSA-N | CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2 | |
| 40 | P28223_DB01142 | DB01142 | Doxepin | antagonist | ODQWQRRAPPTVAG-UHFFFAOYSA-N | [H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12 | |
| 41 | P28223_DB01149 | DB01149 | Nefazodone | antagonist | Ki(nM) = 5.8 | VRBKIVRKKCLPHA-UHFFFAOYSA-N | CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1 |
| 42 | P28223_DB01151 | DB01151 | Desipramine | antagonist | Ki(nM) = 160.0 | HCYAFALTSJYZDH-UHFFFAOYSA-N | CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
| 43 | P28223_DB01175 | DB01175 | Escitalopram | inhibitor | WSEQXVZVJXJVFP-FQEVSTJZSA-N | CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1 | |
| 44 | P28223_DB01186 | DB01186 | Pergolide | agonist | Ki(nM) = 8.32 | YEHCICAEULNIGD-MZMPZRCHSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC |
| 45 | P28223_DB01200 | DB01200 | Bromocriptine | agonist | Ki(nM) = 107.15 | OZVBMTJYIDMWIL-AYFBDAFISA-N | [H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C |
| 46 | P28223_DB01224 | DB01224 | Quetiapine | antagonist | Ki(nM) = 31.0 | URKOMYMAXPYINW-UHFFFAOYSA-N | OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12 |
| 47 | P28223_DB01238 | DB01238 | Aripiprazole | antagonist | Ki(nM) = 0.8 IC50(nM) = 1100.0 | CEUORZQYGODEFX-UHFFFAOYSA-N | ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl |
| 48 | P28223_DB01239 | DB01239 | Chlorprothixene | antagonist | WSPOMRSOLSGNFJ-AUWJEWJLSA-N | CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12 | |
| 49 | P28223_DB01242 | DB01242 | Clomipramine | antagonist | Ki(nM) = 35.5 | GDLIGKIOYRNHDA-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2 |
| 50 | P28223_DB01267 | DB01267 | Paliperidone | antagonist | Ki(nM) = 0.43 IC50(nM) = 5.2 | PMXMIIMHBWHSKN-UHFFFAOYSA-N | CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1 |
| 51 | P28223_DB01392 | DB01392 | Yohimbine | antagonist | Ki(nM) = 252.0 | BLGXFZZNTVWLAY-SCYLSFHTSA-N | [H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2 |
| 52 | P28223_DB01403 | DB01403 | Methotrimeprazine | antagonist | VRQVVMDWGGWHTJ-CQSZACIVSA-N | COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1 | |
| 53 | P28223_DB01442 | DB01442 | MMDA | agonist | YQYUWUKDEVZFDB-UHFFFAOYSA-N | COC1=CC(CC(C)N)=CC2=C1OCO2 | |
| 54 | P28223_DB01454 | DB01454 | Midomafetamine | agonist | SHXWCVYOXRDMCX-UHFFFAOYSA-N | CNC(C)CC1=CC2=C(OCO2)C=C1 | |
| 55 | P28223_DB01488 | DB01488 | Dimethyltryptamine | n/a | Ki(nM) = 65.0 EC50(nM) = 22.0 | DMULVCHRPCFFGV-UHFFFAOYSA-N | CN(C)CCC1=CNC2=CC=CC=C12 |
| 56 | P28223_DB01537 | DB01537 | 4-Bromo-2,5-dimethoxyphenethylamine | partial agonist | Ki(nM) = 0.66 | YMHOBZXQZVXHBM-UHFFFAOYSA-N | COC1=CC(Br)=C(OC)C=C1CCN |
| 57 | P28223_DB01614 | DB01614 | Acepromazine | antagonist | NOSIYYJFMPDDSA-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O | |
| 58 | P28223_DB01618 | DB01618 | Molindone | antagonist | Ki(nM) = 320.0 | KLPWJLBORRMFGK-UHFFFAOYSA-N | CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2 |
| 59 | P28223_DB01621 | DB01621 | Pipotiazine | antagonist | JOMHSQGEWSNUKU-UHFFFAOYSA-N | CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1 | |
| 60 | P28223_DB01623 | DB01623 | Thiothixene | antagonist | GFBKORZTTCHDGY-UWVJOHFNSA-N | CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1 | |
| 61 | P28223_DB01624 | DB01624 | Zuclopenthixol | antagonist | WFPIAZLQTJBIFN-DVZOWYKESA-N | OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1 | |
| 62 | P28223_DB04599 | DB04599 | Aniracetam | n/a | ZXNRTKGTQJPIJK-UHFFFAOYSA-N | COC1=CC=C(C=C1)C(=O)N1CCCC1=O | |
| 63 | P28223_DB04842 | DB04842 | Fluspirilene | antagonist | Ki(nM) = 9.5 | QOYHHIBFXOOADH-UHFFFAOYSA-N | FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1 |
| 64 | P28223_DB04908 | DB04908 | Flibanserin | antagonist | PPRRDFIXUUSXRA-UHFFFAOYSA-N | FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1 | |
| 65 | P28223_DB04946 | DB04946 | Iloperidone | antagonist | Ki(nM) = 0.12 | XMXHEBAFVSFQEX-UHFFFAOYSA-N | COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O |
| 66 | P28223_DB05316 | DB05316 | Pimavanserin | inverse agonist | Ki(nM) = 0.24 IC50(nM) = 1.9 | RKEWSXXUOLRFBX-UHFFFAOYSA-N | CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1 |
| 67 | P28223_DB05492 | DB05492 | Epicept NP-1 | n/a | FKZUPMCBVURANR-UHFFFAOYSA-N | CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O | |
| 68 | P28223_DB06016 | DB06016 | Cariprazine | antagonist | Ki(nM) = 19.0 | KPWSJANDNDDRMB-QAQDUYKDSA-N | CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1 |
| 69 | P28223_DB06077 | DB06077 | Lumateperone | antagonist | HOIIHACBCFLJET-SFTDATJTSA-N | [H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C | |
| 70 | P28223_DB06144 | DB06144 | Sertindole | antagonist | Ki(nM) = 0.14 | GZKLJWGUPQBVJQ-UHFFFAOYSA-N | FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2 |
| 71 | P28223_DB06148 | DB06148 | Mianserin | antagonist | UEQUQVLFIPOEMF-UHFFFAOYSA-N | CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21 | |
| 72 | P28223_DB06153 | DB06153 | Pizotifen | antagonist | FIADGNVRKBPQEU-UHFFFAOYSA-N | CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2 | |
| 73 | P28223_DB06216 | DB06216 | Asenapine | antagonist | Ki(nM) = 0.26 | VSWBSWWIRNCQIJ-UHFFFAOYSA-N | CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1 |
| 74 | P28223_DB06229 | DB06229 | Ocaperidone | n/a | ZZQNEJILGNNOEP-UHFFFAOYSA-N | CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12 | |
| 75 | P28223_DB06288 | DB06288 | Amisulpride | antagonist | Ki(nM) = 631.0 | NTJOBXMMWNYJFB-UHFFFAOYSA-N | CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC |
| 76 | P28223_DB06446 | DB06446 | Dotarizine | n/a | LRMJAFKKJLRDLE-UHFFFAOYSA-N | C(CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)CC1(OCCO1)C1=CC=CC=C1 | |
| 77 | P28223_DB06512 | DB06512 | Deramciclane | antagonist | QOBGWWQAMAPULA-RLLQIKCJSA-N | [H][C@]12CC[C@](C)(C1(C)C)[C@@](C2)(OCCN(C)C)C1=CC=CC=C1 | |
| 78 | P28223_DB08810 | DB08810 | Cinitapride | antagonist | ZDLBNXXKDMLZMF-UHFFFAOYSA-N | CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O | |
| 79 | P28223_DB08815 | DB08815 | Lurasidone | antagonist | Ki(nM) = 2.0 | PQXKDMSYBGKCJA-CVTJIBDQSA-N | [H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O |
| 80 | P28223_DB08839 | DB08839 | Serotonin | n/a | QZAYGJVTTNCVMB-UHFFFAOYSA-N | NCCC1=CNC2=CC=C(O)C=C12 | |
| 81 | P28223_DB08922 | DB08922 | Perospirone | inverse agonist | FBVFZWUMDDXLLG-HDICACEKSA-N | [H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O | |
| 82 | P28223_DB08927 | DB08927 | Amperozide | antagonist | NNAIYOXJNVGUOM-UHFFFAOYSA-N | [H]N(CC)C(=O)N1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1 | |
| 83 | P28223_DB09061 | DB09061 | Cannabidiol | agonist | QHMBSVQNZZTUGM-ZWKOTPCHSA-N | CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1 | |
| 84 | P28223_DB09128 | DB09128 | Brexpiprazole | antagonist | Ki(nM) = 0.47 | ZKIAIYBUSXZPLP-UHFFFAOYSA-N | O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1 |
| 85 | P28223_DB09167 | DB09167 | Dosulepin | antagonist | PHTUQLWOUWZIMZ-GZTJUZNOSA-N | CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12 | |
| 86 | P28223_DB09194 | DB09194 | Etoperidone | antagonist | IZBNNCFOBMGTQX-UHFFFAOYSA-N | CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC | |
| 87 | P28223_DB09195 | DB09195 | Lorpiprazole | antagonist | BNRMWKUVWLKDQJ-YJBOKZPZSA-N | [H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2 | |
| 88 | P28223_DB09223 | DB09223 | Blonanserin | antagonist | Ki(nM) = 0.81 | XVGOZDAJGBALKS-UHFFFAOYSA-N | CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1 |
| 89 | P28223_DB09225 | DB09225 | Zotepine | antagonist | Ki(nM) = 0.5 | HDOZVRUNCMBHFH-UHFFFAOYSA-N | CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12 |
| 90 | P28223_DB09286 | DB09286 | Pipamperone | agonist | Ki(nM) = 5.4 | AXKPFOAXAHJUAG-UHFFFAOYSA-N | NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1 |
| 91 | P28223_DB12163 | DB12163 | Sarpogrelate | inverse agonist | FFYNAVGJSYHHFO-UHFFFAOYSA-N | COC1=CC(CCC2=CC=CC=C2OCC(CN(C)C)OC(=O)CCC(O)=O)=CC=C1 | |
| 92 | P28223_DB12177 | DB12177 | Eplivanserin | n/a | VAIOZOCLKVMIMN-PRJWTAEASA-N | CN(C)CCO\N=C(\C=C\C1=CC=C(O)C=C1)/C1=CC=CC=C1F | |
| 93 | P28223_DB12465 | DB12465 | Ketanserin | inverse agonist | FPCCSQOGAWCVBH-UHFFFAOYSA-N | FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1 | |
| 94 | P28223_DB12555 | DB12555 | Nelotanserin | n/a | COSPVUFTLGQDQL-UHFFFAOYSA-N | COC1=CC=C(NC(=O)NC2=CC=C(F)C=C2F)C=C1C1=C(Br)C=NN1C | |
| 95 | P28223_DB12693 | DB12693 | Ritanserin | inverse agonist | JUQLTPCYUFPYKE-UHFFFAOYSA-N | CC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CSC2=N1 | |
| 96 | P28223_DB13940 | DB13940 | 2,5-Dimethoxy-4-ethylthioamphetamine | agonist | MCYCODJKXUJSAT-UHFFFAOYSA-N | CCSC1=CC(OC)=C(CC(C)N)C=C1OC | |
| 97 | P28223_DB13948 | DB13948 | N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine | agonist | VWEDZTZAXHMZIL-UHFFFAOYSA-N | COC1=CC(C#N)=C(OC)C=C1CCNCC1=C(O)C=CC=C1 | |
| 98 | P28223_DB14010 | DB14010 | 5-methoxy-N,N-dimethyltryptamine | agonist | ZSTKHSQDNIGFLM-UHFFFAOYSA-N | COC1=CC=C2NC=C(CCN(C)C)C2=C1 | |
| 99 | P28223_DB14011 | DB14011 | Nabiximols | n/a | SSNHGLKFJISNTR-DYSNNVSPSA-N | [H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C | |
| 100 | P28223_DB14185 | DB14185 | Aripiprazole lauroxil | antagonist | DDINXHAORAAYAD-UHFFFAOYSA-N | CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12 | |
| 101 | P28223_DB16351 | DB16351 | Volinanserin | antagonist | HXTGXYRHXAGCFP-OAQYLSRUSA-N | COC1=C(OC)C(=CC=C1)[C@H](O)C1CCN(CCC2=CC=C(F)C=C2)CC1 |